Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.48 |
| ▸ | GLP1R | P43220 | 4/20 | 0.47 |
| ▸ | VIPR1 | P32241 | 2/20 | 0.46 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.46 |
| ▸ | VIPR2 | P41587 | 1/20 | 0.45 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.45 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.45 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.45 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.45 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.45 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.45 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29777781 | 0.92 | RAMP3 (0.47) | TFPIOPRL1 | |
| SCHEMBL30432511 | 0.90 | TFPI (0.52) | TFPIGLP1RVIPR1 | |
| SCHEMBL29777749 | 0.89 | TFPI (0.50) | TFPIGLP1ROPRL1GRIN2DGRIN3B | |
| SCHEMBL30423734 | 0.89 | NMT1 (0.50) | TFPIGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL30512522 | 0.88 | TFPI (0.51) | TFPIGLP1ROPRL1GRIN2DGRIN3B | |
| SCHEMBL30536311 | 0.88 | VIPR1 (0.55) | TFPIGLP1RVIPR1VIPR2 | |
| SCHEMBL29777893 | 0.86 | RXFP1 (0.48) | TFPIGLP1RGRIN2DGRIN3BGRIN1 | |
| SCHEMBL30973983 | 0.86 | NMT1 (0.49) | TFPIOPRL1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL30536309 | 0.86 | BACE1 (0.41) | VIPR1VIPR2GRIN2DGRIN3BGRIN1 | |
| SCHEMBL30262131 | 0.86 | TFPI (0.51) | TFPIGLP1RVIPR1OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230263881-A1 | Vaccine compositions for SARS-related coronaviruses and methods of use | ASCIONE RICHARD (US) | 2023-08-24 | — | — | US | disclosed |